Cataract Surgery Outcomes in Patients With Axenfeld-Rieger Syndrome

Area of Science:

• Ophthalmology
• Genetics
• Surgical Outcomes

Background:

• Axenfeld-Rieger syndrome (ARS) is a rare genetic disorder affecting eye development.
• Cataract formation is a common complication in ARS patients.
• Surgical management of cataracts in ARS requires careful consideration of associated ocular comorbidities.

Purpose of the Study:

• To evaluate the safety and efficacy of phacoemulsification with intraocular lens (IOL) implantation in patients diagnosed with Axenfeld-Rieger syndrome (ARS).
• To analyze the visual outcomes and complication rates following cataract surgery in this specific patient cohort.

Main Methods:

• Retrospective observational study design.
• Inclusion criteria: Patients with ARS undergoing cataract surgery with a minimum 6-week postoperative follow-up.
• Evaluation of visual acuity and postoperative complications.

Main Results:

• Phacoemulsification with IOL implantation was performed uneventfully in all cases.
• Significant improvement in best-corrected visual acuity (BCVA) was observed (0.9 to 0.4 LogMAR, P=0.0043).
• High incidence of secondary glaucoma (50%) requiring surgical intervention and corneal decompensation (2 patients requiring DSAEK) were noted.

Conclusions:

• Cataract surgery with IOL implantation is a safe procedure for patients with ARS.
• Achieving optimal visual improvement is contingent upon the management of pre-existing conditions like glaucoma and corneal issues.
• Long-term monitoring for glaucoma and corneal health is crucial in ARS patients post-cataract surgery.